The Story of A14

Nanocare Technologies, Inc was founded in 2010 on the back of nearly 15 years of research and development by cofounder / CSO José Emilio (“Milo”) Fehr Pereira Lopes MD, PhD on an analog of methyl jasmonate as an anti-cancer therapeutic.

Nanocare is a preclinical stage

company focused on improving the

treatment of cancer.

© NANOCARE 2017               PRIVACY POLICY              LEGAL NOTICE               LEGAL DISCLAIMER               CONTACT US


This site is governed by applicable U.S. laws and governmental regulations. Use of this site constitutes your consent to application of such laws and regulations and to our Privacy Policy. Your use of the information on this site is subject to the terms of our Legal Notice. To Contact Us or search this site, please see the links on our Home page. All contents © 2013 Nanocare. All rights reserved.